Jane Street Group, LLC Intra Cellular Therapies, Inc. Call Options Transaction History

Jane Street Group, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	SELL	$38.74 - $62.09 $1.89 Million - $3.03 Million	-48,800 Reduced 39.74%	74,000 $4.53 Million
Q4 2021 Feb 15, 2022	BUY	$35.2 - $53.42 $2.48 Million - $3.76 Million	70,400 Added 134.35%	122,800 $6.43 Million
Q3 2021 Nov 16, 2021	BUY	$28.72 - $42.49 $514,088 - $760,571	17,900 Added 51.88%	52,400 $1.95 Million
Q2 2021 Aug 16, 2021	BUY	$29.3 - $44.5 $691,480 - $1.05 Million	23,600 Added 216.51%	34,500 $1.41 Million
Q1 2021 May 18, 2021	SELL	$30.8 - $39.51 $397,320 - $509,679	-12,900 Reduced 54.2%	10,900 $370,000
Q4 2020 Feb 17, 2021	SELL	$23.34 - $32.22 $1.34 Million - $1.85 Million	-57,300 Reduced 70.65%	23,800 $757,000
Q3 2020 Nov 17, 2020	SELL	$17.61 - $31.86 $2.6 Million - $4.7 Million	-147,500 Reduced 64.52%	81,100 $2.08 Million
Q2 2020 Aug 17, 2020	BUY	$14.35 - $26.64 $3.09 Million - $5.74 Million	215,300 Added 1618.8%	228,600 $5.87 Million
Q1 2020 May 15, 2020	SELL	$12.31 - $33.12 $1.85 Million - $4.96 Million	-149,900 Reduced 91.85%	13,300 $204,000
Q4 2019 Feb 14, 2020	BUY	$7.26 - $38.49 $1.18 Million - $6.28 Million	163,200 New	163,200 $5.6 Million

402

89.5M

301K

277K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $8.62B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.